NEXT

Scott Flaherty

Scott Flaherty

Scott Flaherty, based in New York, covers the business of law with a focus on legal ethics, lawyer misconduct, conflicts-of-interest and litigation involving law firms. He can be reached at [email protected]. On Twitter: @sflaherty18

Connect with this author

December 21, 2014 | Litigation Daily

Cohen Milstein Partner Dominates Report on State AG Contingency Litigation

Former Washington, D.C., attorney general Linda Singer bore the brunt of a skeptical New York Times report on private firms that coax state AGs into action.

By Scott Flaherty

2 minute read

December 19, 2014 | Litigation Daily

Target Suffers New Blow in Data Breach Case

Just weeks after Target Corp. failed to escape claims that it's liable for a massive data breach that cost banks billions of dollars, a judge refused to dismiss most of a proposed consumer class action over the same late-2013 hack attack.

By Scott Flaherty

3 minute read

December 18, 2014 | Litigation Daily

St. Louis Lawyer Scores Again in BofA Whistleblower Case

David Wasinger's whistleblower clients helped the government collect a whopping $2.2 billion from Bank of America and JPMorgan this year. They've been awarded roughly $123 million for their troubles, suggesting that Wasinger and his tiny firm will be enjoying happy holidays indeed this month.

By Scott Flaherty

3 minute read

December 17, 2014 | Litigation Daily

Broadcasters Pursue Aereo in Bankruptcy Tug-of-War

After driving online TV startup Aereo out of business, the broadcast networks are fighting to lift a hold on litigation stemming from the company's Chapter 11 filing so they can press their infringement claims and secure their pound of flesh.

By Scott Flaherty

3 minute read

December 16, 2014 | Litigation Daily

Cohen Milstein Fends Off DQ Bid in Opioids Marketing Case

Accused of inundating the country with addictive painkillers, drug companies went on the attack against their accusers. This week plaintiffs lawyers representing the city of Chicago took a step toward putting the drugmakers back on the defensive.

By Scott Flaherty

4 minute read

December 16, 2014 | Litigation Daily

A&P, Wachtell Join Namenda Fight as Actavis Appeals Injunction

Less than a week after a judge blocked Actavis from forcing patients to switch to new version of its Alzheimer's drug Namenda, the company brought on new legal firepower from Arnold & Porter and Wachtell, Lipton, Rosen & Katz to take the case to the Second Circuit.

By Scott Flaherty

3 minute read

December 15, 2014 | Litigation Daily

SEC Drops Insider Trading Case over Herbalife Short

The Securities and Exchange Commission's enforcement action against an accused insider trader appears to have unraveled, as the agency admitted Monday that it can't produce two key witnesses to testify about an alleged tip-off regarding Herbalife Ltd.

By Scott Flaherty

3 minute read

December 12, 2014 | Litigation Daily

Wilmer's Waxman To Take on Spider-Man Toy Inventor in Marvel Royalties Row

In a case pitting former U.S. solicitor general Seth Waxman against a solo attorney who invented a web-slinging toy with his son, the Supreme Court agreed to reconsider 50-year-old precedent on whether royalty requirements can extend beyond a patent's expiration.

By Scott Flaherty

3 minute read

December 12, 2014 | Litigation Daily

SEC Wins a Round in Battle over Agency Actions

A Manhattan federal judge has injected new doubts into a string of cases challenging an increasingly common tactic by the Securities and Exchange Commission: pursuing fraud and insider trading claims in agency enforcement proceedings, rather than in federal court.

By Scott Flaherty

4 minute read

December 11, 2014 | Litigation Daily

FINRA Fines Banks for Mixing Research, Investment Banking Biz

A decade after a crackdown that was supposed to rein in research conflicts at Wall Street banks, the industry's self-regulator levied $43.5 million in penalties Thursday against 10 leading banks accused of using their research analysts to drum up investment banking business.

By Scott Flaherty

2 minute read